European Pharmaceutical Review

JULY 11, 2023

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) has highlighted the importance of post-approval R&D in advancing oncology treatment options and delivering unprecedented progress over the past ten years. This therefore broadens the population of patients who may benefit.

Food and Drug Administration 74

Food and Drug Administration Medicine Pharmaceutical research FDA 74

Pharmaceutical Technology

MAY 17, 2023

Merith Basey, the executive director of the advocacy group Patients for Affordable Drugs, said that CMS’s lack of negotiating power is a key reason that US patients pay up to four times as much for drugs as patients in other countries.

Food and Drug Administration 52

Food and Drug Administration Pharma Patients Pharmaceutical research 52

Pharmaceutical Technology

DECEMBER 21, 2022

In pharmaceutical research, this may help secure the privacy of patient data used by AI systems and decrease bias due to ethnicity, sex and other factors. FDA and EMA action.

Pharma 140

Pharma Pharmaceutical Medicine Government 140

Pharmaceutical Technology

APRIL 12, 2023

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. Globally, non-human primates make up a relatively small percentage of the animals used in research. The ABPI points to the FDA in the US as an example.

Pharma 98

Pharma Food and Drug Administration Safety Medicine 98

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97